A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus Type 2

In brief

This study will assess the efficacy, safety and tolerability of DPP-IV Inhibitor in patients with type 2 diabetes receiving a stable dose of metformin. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.

Key facts

Study ID

NCT00111631

Run by

Hoffmann-La Roche

People needed

218

Starts

2005-05-01

Expected to finish

2006-10-01

Last updated by the study team

2016-11-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients 18-75 years of age;
• type 2 diabetes;
• stable metformin therapy for >=3 months before screening.

You may not qualify if…

• women who are pregnant, breast-feeding, or not using an adequate contraceptive method;
• type 1 diabetes;
• any anti-hyperglycemic medication other than metformin in the last 3 months.

Where it is running

• Study site — Concord, California, United States
• Study site — Salinas, California, United States
• Study site — San Diego, California, United States
• Study site — Boulder, Colorado, United States
• Study site — Newark, Delaware, United States
• Study site — Wilmington, Delaware, United States
• Study site — Clearwater, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Detroit, Michigan, United States
• Study site — Buffalo, New York, United States
• Study site — Rochester, New York, United States
• Study site — Durham, North Carolina, United States
• Study site — Mogadore, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Connellsville, Pennsylvania, United States
• Study site — Warminster, Pennsylvania, United States
• Study site — Dallas, Texas, United States
• Study site — Midland, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Adelaide, Australia
• Study site — Sydney, Australia
• Study site — Winnipeg, Manitoba, Canada
• Study site — Halifax, Nova Scotia, Canada
• Study site — London, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.